Sinofn Health
Sinofn Health
In the rapidly evolving global nutraceutical market, the demand for science-driven, high-efficacy formulations is at an all-time high. SINOFN Health Co., Ltd., established in 2025 as the specialized OEM division of the SINOFN Group (founded 2012), bridges the gap between deep-tech research and global commercial availability. Backed by the Chinese Academy of Sciences (CAS), we do not merely manufacture supplements; we engineer health solutions.
Our operational model is built on transparency, regulatory compliance, and a "profit with purpose" philosophy. Whether you are a budding wellness startup looking for rapid prototyping or an enterprise requiring large-scale GMP production, SINOFN provides a robust, scalable infrastructure that respects your intellectual property while accelerating your go-to-market timeline.
The modern consumer is more educated than ever. They seek evidence-based products, not marketing fluff. As a trusted private label partner, SINOFN observes three critical trends driving the market:
Driven by clinical experience in treating PKU children, Mrs. Liu founded SINOFN with a mission to make clinical-grade nutrition accessible. Her vision shapes our R&D-first approach.
Ph.D. from Peking University Medical School. With 15+ years in metabolic disorder formulations, he leads our Medical Innovation department.
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems, ensuring our supplements perform at the molecular level.
We operate 10+ specialized production lines with an annual capacity exceeding 500 million units, covering softgels, gummies, powders, and liquids, all GMP certified.
We act as a Shanghai-based trading and manufacturing hub, providing streamlined logistics, regulatory consulting, and documentation support to ensure smooth import into your specific region.
Yes. Our R&D center provides pilot-scale prototyping. We help you move from concept to market-ready product with stability testing and bioavailability validation.
